Creative Capital Management Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.8K Sell
52
-1
-2% -$1.01K 0.01% 118
2025
Q4
$57K Buy
53
+1
+2% +$956 0.02% 112
2025
Q3
$39.7K Hold
52
0.01% 123
2025
Q2
$40.5K Hold
52
0.01% 128
2025
Q1
$42.9K Hold
52
0.02% 117
2024
Q4
$40.1K Hold
52
0.02% 118
2024
Q3
$46.1K Hold
52
0.02% 97
2024
Q2
$47.1K Buy
52
+3
+6% +$2.4K 0.02% 87
2024
Q1
$38.1K Hold
49
0.02% 99
2023
Q4
$28.6K Hold
49
0.02% 108
2023
Q3
$26.3K Hold
49
0.02% 112
2023
Q2
$23K Hold
49
0.02% 110
2023
Q1
$16.8K Buy
+49
New +$16.5K 0.01% 135

Other funds holding LLY

Creative Capital Management Investments's LLY Position: Q1 2026 in Review

Creative Capital Management Investments reduced its Eli Lilly (LLY) stake by 1.9% in Q1 2026, selling an estimated $1.01K and leaving 52 shares worth $47.8K. The position accounts for 0.01% of the portfolio, ranked #118.

Creative Capital Management Investments first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. The position peaked at $57K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Creative Capital Management Investments held 52 shares of Eli Lilly worth $47.8K as of Q1 2026.
  • Creative Capital Management Investments sold 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.01% of Creative Capital Management Investments's portfolio in Q1 2026, its #118 holding.
  • Creative Capital Management Investments first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
  • Creative Capital Management Investments's Eli Lilly position peaked at $57K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Creative Capital Management Investments's 13F filing for Q1 2026, filed 21 Apr 2026.